Labetalol S.A.L.F.

Labetalol, the active ingredient in Labetalol S.A.L.F., is an alpha/beta adrenergic antagonist presented as an intravenous solution for parenteral use. It is employed to manage hypertension and hypertensive emergencies in adult patients. GNH USA supplies Labetalol S.A.L.F. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Labetalol is an antihypertensive agent that acts on both alpha‑1 and beta‑adrenergic receptors to lower blood pressure. - Hypertension: provides sustained reduction of systemic arterial pressure in chronic hypertension. - Hypertensive emergencies: enables rapid blood pressure control in acute severe hypertension. - Pregnancy‑induced hypertension: offers safe blood pressure management when other agents are contraindicated.

Labetalol may cause a range of adverse reactions, some of which are more frequent than others.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after dose changes. - Headache: mild to moderate intensity, often transient. - Fatigue: generalized tiredness without exertion. - Nausea: occasional upset stomach or urge to vomit. - Flushing: warm sensation and reddening of the skin. - Nasal congestion: feeling of blocked nasal passages.

Serious or Rare Side Effects: - Severe hypotension: dangerously low blood pressure requiring medical intervention. - Bronchospasm: narrowing of airways, particularly in patients with asthma. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Cardiac conduction abnormalities: heart block or arrhythmias. - Stevens‑Johnson syndrome: rare severe skin reaction. - Acute heart failure: worsening of cardiac function in susceptible individuals.

When using Labetalol, clinicians should observe several safety measures. - Blood pressure monitoring: check regularly to avoid excessive hypotension. - Asthma caution: use carefully in patients with reactive airway disease due to possible bronchospasm. - Hepatic impairment: consider dose adjustment or alternative therapy in liver disease. - Abrupt discontinuation: avoid sudden stop to prevent rebound hypertension. - Renal dysfunction: monitor renal function and adjust dosing as needed. - Store at ambient temperature: keep in original container, protect from moisture and light.

Labetalol can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension. - Other antihypertensives: additive hypotensive effect. - Additional beta‑blockers: excessive bradycardia or heart block. - Calcium channel blockers: heightened blood pressure lowering. - Clonidine: possible rebound hypertension on withdrawal.

Moderate Interactions (Monitor Closely): - NSAIDs: may diminish antihypertensive response. - Diuretics: can cause electrolyte imbalances. - Insulin or oral hypoglycemics: may mask hypoglycemia symptoms. - Anesthetic agents: may potentiate cardiovascular depression. - Certain antidepressants: monitor for altered blood pressure control.